Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

'Low ticket sales'
‘I have ugly teeth’
Cocaine found in blood
Alleged Ponzi scheme
Held own intervention
Benefit increasing
85 beverages recalled
No-show for Ga. court
Collapses in NY heat
CEO's sad selfie
Right-only dating app
Impaled by umbrella
FBI office shoot-out
Jet skims spectators
Under house arrest
Ex-husband called out
Killed by leg bomb
Murder investigation
Divorce after 6 years
CEO ‘socialist’ rant
Seeking new trial
Homicide suspected
Doorbell camera show
Roller coaster crash
Permanently retired
Shooting outside gym
Reveals water strategy
Baby left in hot car
Jokes about hit price
Seeks warrant release
Children found safe
Teen flood hero dies
Earth gas in moon rock
40% more lead in eggs
Sea sponges sneeze
CDC loosens guidance
Methane super emitters
Non-intentional doping
Last supermoon of 2022
Ex-Va. cop sentenced
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
13 results
BioNTech, Pfizer could deliver Omicron-adapted COVID-19 vaccines in October
BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...
UPI.com on MSN.com
3d
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce Trials
BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...
Forbes on MSN.com
3d
COVID-19 vaccine maker BioNTech expects updated omicron-specific shots by October
BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...
Washington Examiner on MSN.com
3d
Pfizer, BioNTech to study 'bivalent' booster as FDA weighs approach
The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...
BioPharma Dive
15d
U.S. to Offer Updated COVID Booster Shots in September
The Biden administration plans to begin a COVID-19 booster campaign with reformulated vaccines in September. The new boosters ...
WebMD
8d
Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
We need vaccines with longer duration and greater breadth of protection,' said Dr. David Kessler, chief science officer for ...
MarketWatch on MSN.com
13d
Poll: Most older, vaccinated Americans will get updated booster shots
Most older U.S. adults are prepared to roll up their sleeves to get an updated COVID-19 booster shot once one becomes ...
UPI.com on MSN.com
1d
BioNTech reports strong first half, expects demand to grow
BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported higher revenue and net profit in the ...
ABC
3d
UPDATE 2-BioNTech expects Omicron-adapted vaccine deliveries as soon as October
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, the German biotech firm said on Monday as it reaffirmed its ...
YAHOO!Finance
3d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
This is the first of multiple vaccine candidates with an enhanced design which the companies plan to evaluate as part of a long-term scientific COVID-19 vaccine strategy to potentially generate more ...
Associated Press
15d
BioNTech Announces Second Quarter Financial Results and Corporate Update
Second quarter revenues of EUR3.2 billion1, net profit of EUR1.7 billion and fully diluted earnings per share of EUR6.45 ($6.872) as well as first half ...
MarketWatch
3d
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation ...
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind Phase ...
The Bakersfield Californian
15d
© 2022 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback